ANEB · Anebulo Pharmaceuticals, Inc.
$0.33
+0.00 (+0.00%)
At close · Jul 30
Market Cap
$13.46M
Shares
40.78M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Simon Allen | CEO | $2,120,841 |
| Kenneth C. Cundy | Chief Scientific Officer | $490,357 |
| Rex Merchant | CFO | $275,000 |
| Daniel Schneeberger | CEO | $8,797 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Daniel Schneeberger | CEO | $120,416 |
| Rex Merchant | CFO | $119,792 |